Table 3.
Adverse events | OME | PAN | LAN | RAB | ILA | RAN | FAM | PLA |
---|---|---|---|---|---|---|---|---|
Headache (%) | 2.57 | 1.79 | 1.88 | 3.49 | 0.46 | 2.70 | 3.20 | 4.21 |
Diarrhea (%) | 1.58 | 1.54 | 1.16 | 2.30 | 1.83 | 1.70 | 1.14 | 3.92 |
Nausea (%) | 2.14 | 1.02 | 1.73 | 0.53 | NR | 0.88 | 1.90 | 3.92 |
Rash (%) | 1.01 | 1.10 | 1.60 | 1.47 | NR | 0.76 | 0.92 | NR |
Vomiting (%) | 0.25 | NR | NR | 0.53 | 2.02 | 0.57 | 1.11 | 3.92 |
Dizziness (%) | 1.52 | 2.05 | 1.05 | NR | NR | 0.81 | 0.84 | NR |
Constipation (%) | 0.18 | 0.80 | 2.21 | NR | NR | 0.63 | 1.32 | NR |
Myalgia | 0.84 | 0.48 | 1.05 | 0.53 | NR | 0.59 | NR | NR |
Loss of appetite (%) | 2.36 | NR | 1.82 | NR | 2.11 | NR | 1.17 | NR |
Insomnia (%) | 1.09 | 2.50 | 1.82 | NR | NR | NR | 0.84 | NR |
Dry mouth (%) | 2.37 | 2.17 | 0.80 | NR | NR | NR | 1.27 | NR |
Psychiatric disorder (%) | 2.84 | NR | 0.42 | NR | NR | 1.85 | 1.41 | NR |
Cardiovascular disorder (%) | 0.33 | NR | 0.57 | 0.53 | NR | 0.84 | NR | NR |
Asthenia (%) | 2.77 | NR | 2.87 | NR | NR | 0.44 | NR | NR |
Somnolence (%) | 1.12 | NR | NR | NR | NR | 1.22 | 0.78 | NR |
Abdominal distension (%) | 1.58 | NR | NR | NR | NR | 1.91 | 2.20 | NR |
Abnormal liver function (%) | 1.23 | 1.02 | NR | NR | 3.63 | NR | NR | NR |
Renal impairment (%) | 0.19 | NR | NR | NR | 1.45 | 0.94 | NR | NR |
NR, not reported. OME, omeprazole, 20 mg/day; PAN, pantoprazole, 40 mg/day; LAN, lansoprazole, 30 mg/day; RAB, rabeprazole, 20 mg/day; ILA, ilaprazole, 10 mg/day; RAN, ranitidine, 300 mg/day; FAM, famotidine, 40 mg/day; PLA, placebo.